PT  - JOURNAL ARTICLE
AU  - Nash, Denis
AU  - Qasmieh, Saba
AU  - Robertson, McKaylee
AU  - Rane, Madhura
AU  - Zimba, Rebecca
AU  - Kulkarni, Sarah
AU  - Berry, Amanda
AU  - You, William
AU  - Mirzayi, Chloe
AU  - Westmoreland, Drew
AU  - Parcesepe, Angela
AU  - Waldron, Levi
AU  - Kochhar, Shivani
AU  - Maroko, Andrew R
AU  - Grov, Christian
AU  - ,
TI  - Household factors and the risk of severe COVID-like illness early in the US pandemic
AID  - 10.1101/2020.12.03.20243683
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.12.03.20243683
4099  - http://medrxiv.org/content/early/2020/12/04/2020.12.03.20243683.short
4100  - http://medrxiv.org/content/early/2020/12/04/2020.12.03.20243683.full
AB  - Objective To investigate the role of children in the home and household crowding as risk factors for severe COVID-19 disease.Methods We used interview data from 6,831 U.S. adults screened for the Communities, Households and SARS/CoV-2 Epidemiology (CHASING) COVID Cohort Study in April 2020.Results In logistic regression models, the adjusted odds ratio [aOR] of hospitalization due to COVID-19 for having (versus not having) children in the home was 10.5 (95% CI:5.7-19.1) among study participants living in multi-unit dwellings and 2.2 (95% CI:1.2-6.5) among those living in single unit dwellings. Among participants living in multi-unit dwellings, the aOR for COVID-19 hospitalization among participants with more than 4 persons in their household (versus 1 person) was 2.5 (95% CI:1.0-6.1), and 0.8 (95% CI:0.15-4.1) among those living in single unit dwellings.Conclusion Early in the US SARS-CoV-2 pandemic, certain household exposures likely increased the risk of both SARS-CoV-2 acquisition and the risk of severe COVID-19 disease.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding for this project is provided by the CUNY Institute for Implementation Science in Population Health (cunyisph.org), the COVID-19 Grant Program of the CUNY Graduate School of Public Health and Health Policy, and the National Institute Of Allergy and Infectious Diseases of the National Institutes of Health under Award Number UH3AI133675.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB of the City University of New York Graduate School of Public Health and Health PolicyAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesPlease contact study team. https://cunyisph.org/chasing-covid/